ON THE REGULATION AND CONTROL OF FIBRINOLYSIS: EDWARD KOWALSKI MEMORIAL LECTURECOLLEN D.1980; THROMB. HAEMOST.; ISSN 0340-6245; DEU; DA. 1980; VOL. 43; NO 2; PP. 77-89; BIBL. 162 REF.Article

IDENTIFICATION AND SOME PROPERTIES OF A NEW FAST-REACTING PLASMIN INHIBITOR IN HUMAN PLASMA.COLLEN D.1976; EUROP. J. BIOCHEM.; GERM.; DA. 1976; VOL. 69; PP. 209-216; BIBL. 24 REF.Article

Tissue-type plasminogen activator therapeutic potential in thrombotic disease statesCOLLEN, D.Drugs (Basel). 1986, Vol 31, Num 1, pp 1-5, issn 0012-6667Article

Human tissue-type plasminogen activator: from the laboratory to the bedsideCOLLEN, D.Circulation (New York, N.Y.). 1985, Vol 72, Num 1, pp 18-20, issn 0009-7322Article

DEGRADATION OF THE APOPROTEIN A-I POLYPEPTIDE CHAIN OF HUMAN HIGH DENSITY LIPOPROTEIN BY HUMAN PLASMINLIJNEN HR; COLLEN D.1981; THROMBOSIS RESEARCH; ISSN 0049-3848; USA; DA. 1981; VOL. 24; NO 1-2; PP. 151-156; BIBL. 15 REF.Article

NEUTRALIZATION OF HUMAN EXTRINSIC (TISSUE-TYPE) PLASMINOGEN ACTIVATOR IN HUMAN PLASMA: NO EVIDENCE FOR A SPECIFIC INHIBITORKORNINGER C; COLLEN D.1981; THROMB. HAEMOST.; ISSN 0340-6245; DEU; DA. 1981; VOL. 46; NO 3; PP. 662-665; BIBL. 20 REF.Article

PURIFICATION AND CHARACTERIZATION OF BOVINE COAGULATION FACTOR XII (HAGEMAN FACTOR).CLAEYS H; COLLEN D.1978; EUROP. J. BIOCHEM.; DEU; DA. 1978; VOL. 87; NO 1; PP. 69-74; BIBL. 23 REF.Article

COMPARISON OF THE REACTIONS OF NEUTRAL GRANULOCYTE PROTEASES WITH THE MAJOR PLASMA PROTEASE INHIBITORS AND WITH ANTIPLASMIN.OHLSSON K; COLLEN D.1977; SCAND. CLIN. LAB. INVEST.; NORWAY; DA. 1977; VOL. 37; NO 4; PP. 345-350; BIBL. 16 REF.Article

SYSTEMIC THROMBOLYTIC THERAPY OF ACUTE MYOCARDIAL INFARCTION.COLLEN D; VERSTRAETE M.1983; CIRCULATION; ISSN 0009-7322; USA; DA. 1983; NO 68; 2; PP. 462-465; BIBL. 8 REF.Article

PURIFICATION AND CHARACTERIZATION OF THE PLASMINOGEN ACTIVATOR SECRETED BY HUMAN MELANOMA CELLS IN CULTURERIJKEN DC; COLLEN D.1981; J. BIOL. CHEM.; ISSN 0021-9258; USA; DA. 1981; VOL. 256; NO 13; PP. 7035-7041; BIBL. 37 REF.Article

ALPHA ₂-ANTIPLASMIN CONSUMPTION AND FIBRINOGEN BREAKDOWN DURING THROMBOLYTIC THERAPYCOLLEN D; VERSTRAETE M.1979; THROMBOSIS RES.; GBR; DA. 1979; VOL. 14; NO 4-5; PP. 631-639; BIBL. 23 REF.Article

MOLECULAR MECHANISM OF PHYSIOLOGICAL FIBRINOLYSIS.WIMAN B; COLLEN D.1978; NATURE; G.B.; DA. 1978; VOL. 272; NO 5653; PP. 549-550; BIBL. 19 REF.Article

NEOANTIGENIC EXPRESSION IN ENZYME-INHIBITOR COMPLEXES. A MEANS TO DEMONSTRATE ACTIVATION OF ENZYME SYSTEMS.COLLEN D; DE COCK F.1978; BIOCHIM. BIOPHYS. ACTA; NLD; DA. 1978; VOL. 525; NO 1; PP. 287-290; BIBL. 7 REF.Article

MOLECULAR BIOLOGY OF HUMAN PLASMINOGEN. I. PHYSICOCHEMICAL PROPERTIES AND MICROHETEROGENEITY. = BIOLOGIE MOLECULAIRE DU PLASMINOGENE. I. PROPRIETES PHYSICO-CHIMIQUES ET MICRO-HETEROGENEITECOLLEN D; DE MAEYER L.1975; THROMBOSIS DIATHESIS HAEMORRHAG.; ALLEM.; DA. 1975; VOL. 34; NO 2; PP. 396-402; BIBL. 2 P.Article

Towards improved thrombolytic therapyCOLLEN, D.Lancet (British edition). 1993, Vol 342, Num 8862, pp 34-36, issn 0140-6736Article

Mechanisms of inhibition of tissue-type plasminogen activator in bloodCOLLEN, D.Thrombosis and haemostasis. 1983, Vol 50, Num 3, issn 0340-6245, 678Article

IMMUNOCHEMICAL CHARACTERIZATION OF A LOW AFFINITY LYSINE BINDING SITE WITHIN PLASMINOGENPLOW EF; COLLEN D.1981; J. BIOL. CHEM.; ISSN 0021-9258; USA; DA. 1981; VOL. 256; NO 21; PP. 10864-10869; BIBL. 36 REF.Article

ON THE MECHANISM OF THE REACTION BETWEEN HUMAN ALPHA ₂-ANTIPLASMIN AND PLASMINWIMAN B; COLLEN D.1979; J. BIOL. CHEM.; USA; DA. 1979; VOL. 254; NO 18; PP. 9291-9297; BIBL. 32 REF.Article

ON THE KINETICS OF THE REACTION BETWEEN HUMAN ANTIPLASMIN AND PLASMIN.WIMAN B; COLLEN D.1978; EUROP. J. BIOCHEM.; GERM.; DA. 1978; VOL. 84; NO 2; PP. 573-578; BIBL. 19 REF.Article

AFFINITY CHROMATOGRAPHY OF SOLUBLE FIBRIN IN HUMAN PLASMA ON INSOLUBILIZED FIBRINOGEN AND FRAGMENT D.SEMERARO N; COLLEN D.1978; THROMBOSIS RES.; GBR; DA. 1978; VOL. 12; NO 6; PP. 1059-1070; BIBL. 17 REF.Article

PLASMIN-ANTIPLASMIN COMPLEX FORMATION DURING DEFIBRASE INFUSION IN MAN.COLLEN D; VERSTRAETE M.1977; THROMBOSIS RES.; G.B.; DA. 1977; VOL. 11; NO 3; PP. 417-420; BIBL. 10 REF.Article

IMMUNOCHEMICAL DISTINCTION BETWEEN THE INHIBITORS OF PLASMINOGEN ACTIVATION AND ANTIPLASMIN IN HUMAN PLASMA.HEDNER U; COLLEN D.1976; THROMBOSIS RES.; G.B.; DA. 1976; VOL. 8; NO 6; PP. 875-879; BIBL. 7 REF.Article

TURNOVER OF HUMAN HISTIDINE-RICH GLYCOPROTEIN IN HEALTHY SUBJECTS AND DURING THROMBOLYTIC THERAPYLIJNEN HR; DE COX F; COLLEN D et al.1981; THROMB. RES.; ISSN 0049-3848; USA; DA. 1981; VOL. 23; NO 1-2; PP. 121-131; BIBL. 18 REF.Article

ISOLATION AND CHARACTERIZATION OF A HUMAN PLASMA PROTEIN WITH AFFINITY FOR THE LYSINE BINDING SITES IN PLASMINOGEN: ROLE IN THE REGULATION OF FIBRINOLYSIS AND IDENTIFICATION AS HISTIDINE-RICH GLYCOPROTEINLIJNEN HR; HOYLAERTS M; COLLEN D et al.1980; J. BIOL. CHEM.; ISSN 0021-9258; USA; DA. 1980; VOL. 255; NO 21; PP. 10214-10222; BIBL. 40 REF.Article

THROMBOLYSIS WITH HUMAN EXTRINIC (TISSUE-TYPE) PLASMINOGEN ACTIVATOR IN RABBITS WITH EXPERIMENTAL JUGULAR VEIN THROMBOSIS. EFFECT OF MOLECULARFORM AND DOSE OF ACTIVATOR, AGE OF THE THROMBUS, AND ROUTE OF ADMINISTRATIONCOLLEN D; STASSEN JM; VERSTRAETE M et al.1983; JOURNAL OF CLINICAL INVESTIGATION; ISSN 0021-9738; USA; DA. 1983; VOL. 71; NO 2; PP. 368-376; BIBL. 27 REF.Article